Assessment of the Efficacy and Safety of FlutiForm® pMDI 125/5 µg (2 Puffs Bid) Versus Symbicort® Turbohaler® 200/6 µg (2 Puffs Bid) in Adolescent and Adult Subjects With Moderate to Severe Persistent, Reversible Asthma
Clinical trial NCT01099722 · COMPLETED
Trial details
- NCT number
- NCT01099722
- Sponsor
- Mundipharma Research Limited
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-04-01
- Primary completion
- 2010-11-01
- Enrollment
- 261
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.